Literature DB >> 14984267

Local and systemic immune responses to intratracheal instillation of antigen and DNA vaccines in mice.

Catherine Lombry1, Aline Marteleur, Mohammed Arras, Dominique Lison, Jamila Louahed, Jean-Christophe Renauld, Véronique Préat, Rita Vanbever.   

Abstract

PURPOSE: The purpose of this study was to determine the immunization efficacy of antigen and DNA vaccines after delivery to the lung, to assess the integrity of the pulmonary tissue after vaccination, and to elucidate mechanisms involved in the induction of immunity.
METHODS: Ovalbumin, the plasmid encoding ovalbumin, the hepatitis B surface antigen (HBsAg), or plasmid encoding HBsAg were intratracheally instilled or injected in quadriceps in mice. The immune response and its Th polarization were analyzed over time. Markers of inflammation were measured in bronchoalveolar lavage, and lung histology was performed. The fate of ovalbumin following intratracheal instillation was studied.
RESULTS: According to the vaccine, the pulmonary route produced stronger or equivalent humoral and cellular responses systemically and locally in the lung as compared to injection. The IgG subclasses and cytokine pattern indicate that the immunity was preferentially polarized toward the Th2 and Th1 type for antigen and DNA immunization, respectively. Ovalbumin penetrated the respiratory tissue and blood poorly after intratracheal instillation, suggesting that the immune response was triggered at airway surfaces. Overall, vaccines delivered to the lung did not induce any local sign of inflammation.
CONCLUSIONS: Pulmonary administration of vaccines might be a promising alternative to conventional vaccination by injection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14984267     DOI: 10.1023/b:pham.0000012160.00222.55

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.580


  21 in total

Review 1.  DNA vaccines: immunology, application, and optimization*.

Authors:  S Gurunathan; D M Klinman; R A Seder
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Persistence of measles antibody two years after revaccination by aerosol or subcutaneous routes.

Authors:  A Dilraj; F T Cutts; J V Bennett; J Fernandez de Castro; B Cohen; H M Coovadia
Journal:  Pediatr Infect Dis J       Date:  2000-12       Impact factor: 2.129

3.  DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity.

Authors:  J S Boyle; A Silva; J L Brady; A M Lew
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

4.  Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium- or aluminum phosphate.

Authors:  S Wang; X Liu; K Fisher; J G Smith; F Chen; T W Tobery; J B Ulmer; R K Evans; M J Caulfield
Journal:  Vaccine       Date:  2000-01-18       Impact factor: 3.641

5.  Comparison between hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha): composition, structure and immunogenicity.

Authors:  D Diminsky; R Schirmbeck; J Reimann; Y Barenholz
Journal:  Vaccine       Date:  1997 Apr-May       Impact factor: 3.641

6.  Respiratory mechanics and maximal expiratory flow in the anesthetized mouse.

Authors:  Y L Lai; H Chou
Journal:  J Appl Physiol (1985)       Date:  2000-03

7.  Immunization against measles by aerosol.

Authors:  A B Sabin
Journal:  Rev Infect Dis       Date:  1983 May-Jun

8.  Clearance of different-sized proteins from the alveolar space in humans and rabbits.

Authors:  R H Hastings; M Grady; T Sakuma; M A Matthay
Journal:  J Appl Physiol (1985)       Date:  1992-10

9.  The antigen-presenting activities of Ia+ dendritic cells shift dynamically from lung to lymph node after an airway challenge with soluble antigen.

Authors:  W Xia; C E Pinto; R L Kradin
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

10.  Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces.

Authors:  A S McWilliam; D Nelson; J A Thomas; P G Holt
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  7 in total

1.  Particle size influences the immune response produced by hepatitis B vaccine formulated in inhalable particles.

Authors:  Chandan Thomas; Vivek Gupta; Fakhrul Ahsan
Journal:  Pharm Res       Date:  2010-03-16       Impact factor: 4.200

Review 2.  The Multi-Functional Roles of CCR7 in Human Immunology and as a Promising Therapeutic Target for Cancer Therapeutics.

Authors:  Faris Alrumaihi
Journal:  Front Mol Biosci       Date:  2022-07-06

3.  The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response.

Authors:  Antoine Minne; Jamila Louahed; Sybille Mehauden; Benoît Baras; Jean-Christophe Renauld; Rita Vanbever
Journal:  Immunology       Date:  2007-05-22       Impact factor: 7.397

Review 4.  Pulmonary DNA vaccination: concepts, possibilities and perspectives.

Authors:  Maytal Bivas-Benita; Tom H M Ottenhoff; Hans E Junginger; Gerrit Borchard
Journal:  J Control Release       Date:  2005-09-20       Impact factor: 9.776

5.  Development of a DNA Vaccine for Melanoma Metastasis by Inhalation Based on an Analysis of Transgene Expression Characteristics of Naked pDNA and a Ternary Complex in Mouse Lung Tissues.

Authors:  Yukinobu Kodama; Mikiro Nakashima; Tadayuki Nagahara; Natsuko Oyama; Junya Hashizume; Hiroo Nakagawa; Hitomi Harasawa; Takahiro Muro; Tomoaki Kurosaki; Chikamasa Yamashita; Mitsuru Hashida; Takashi Kitahara; Hitoshi Sasaki; Shigeru Kawakami; Tadahiro Nakamura
Journal:  Pharmaceutics       Date:  2020-06-11       Impact factor: 6.321

6.  Pulmonary immunization: deposition site is of minor relevance for influenza vaccination but deep lung deposition is crucial for hepatitis B vaccination.

Authors:  Jasmine Tomar; Wouter F Tonnis; Harshad P Patil; Anne H de Boer; Paul Hagedoorn; Rita Vanbever; Henderik W Frijlink; Wouter L J Hinrichs
Journal:  Acta Pharm Sin B       Date:  2019-05-28       Impact factor: 11.413

Review 7.  Nanotechnologies in Delivery of DNA and mRNA Vaccines to the Nasal and Pulmonary Mucosa.

Authors:  Jie Tang; Larry Cai; Chuanfei Xu; Si Sun; Yuheng Liu; Joseph Rosenecker; Shan Guan
Journal:  Nanomaterials (Basel)       Date:  2022-01-11       Impact factor: 5.076

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.